The HerediGene: Population Study is expected to provide insight into human genetics that can be used to prevent common diseases such as breast cancer, colon cancer and heart disease. It will also deepen understanding of the human genome and improve population health.
The study is voluntary and free to consenting participants, who will have the option to receive a genetic results report of their genomic analysis if a clinically significant gene mutation is identified. The study, comprised mainly of Intermountain patients from Utah and Idaho, represents the largest and most comprehensive DNA mapping project from a single U.S. population.
More articles about health IT:
Medidata to be acquired for $5.8B: 5 things to know
Facebook launches tool for blood bank donations
U of Virginia physicians work with data scientists to develop predictive model for dosing protocols
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
